Metacrine Inc (NASDAQ:MTCR) Stock Takes a Hit: Slips To a New Low

October 25, 2021

Clinical stage biopharmaceutical firm Metacrine Inc (NASDAQ:MTCR) saw its stock take a significant dive this past Friday and it will be interesting to see if the stock is able to make a recovery this week. On Friday, the stock suffered from a massive selloff and went down by as much as 57% as a consequence. Market Action: On Friday, MTCR stock fell 57.44% at $1.6300 with more than 11.46 million…